Revolution Medicines target price raised to $261 from $241
RVMD•Truist Securities raised its target price for Revolution Medicines to $261 from $241.
Related News
Hecla Mining target price cut to $20 from $21
HL•
EagleRock Land LLC: Piper Sandler cuts target price to $29 from $31
EROK•
Edwards Lifesciences target price raised to $118 from $113 by Truist Securities
EW•
McKesson target price raised to $1,200 from $1,070
MCK•
Edwards Lifesciences target price raised to $97 from $85 by Canaccord Genuity
EW•